Cargando…
GPC2 deficiency inhibits cell growth and metastasis in colon adenocarcinoma
Glypican-2 (GPC2) has been reported to promote tumor progression through metabolic pathways. However, the role of GPC2 in colon adenocarcinoma (COAD) remains to be further investigated. This study was designed to evaluate the role of GPC2 in COAD. Based on patients with complete clinical information...
Autores principales: | Lin, Lumin, He, Yanbin, Ni, Zhuona, Zhang, Min, Liu, Jie, Mao, Qianqian, Huang, Bin, Lin, Jiumao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847712/ https://www.ncbi.nlm.nih.gov/pubmed/35233466 http://dx.doi.org/10.1515/med-2022-0421 |
Ejemplares similares
-
ANRIL promotes the regulation of colorectal cancer on lymphatic endothelial cells via VEGF-C and is the key target for Pien Tze Huang to inhibit cancer metastasis
por: Huang, Bin, et al.
Publicado: (2023) -
Chemotherapeutic Drugs Induce Different Gut Microbiota Disorder Pattern and NOD/RIP2/NF-κB Signaling Pathway Activation That Lead to Different Degrees of Intestinal Injury
por: Huang, Bin, et al.
Publicado: (2022) -
GPC1 Is Associated with Poor Prognosis and Treg Infiltration in Colon Adenocarcinoma
por: Liu, Ying, et al.
Publicado: (2022) -
The novel lncRNA GPC5-AS1 stabilizes GPC5 mRNA by competitively binding with miR-93/106a to suppress gastric cancer cell proliferation
por: Bo, Guo, et al.
Publicado: (2022) -
GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma
por: Ning, Jing, et al.
Publicado: (2021)